Atrial fibrosis and the mechanisms of atrial fibrillation

This publication has 60 references indexed in Scilit:

• Pirfenidone Prevents the Development of a Vulnerable Substrate for Atrial Fibrillation in a Canine Model of Heart Failure
  Circulation, 2006
• Effects of the Gap Junction Modifier Rotigaptide (ZP123) on Atrial Conduction and Vulnerability to Atrial Fibrillation
  Circulation, 2006
• Mapping of Atrial Activation During Sustained Atrial Fibrillation in Dogs with Rapid Ventricular Pacing Induced Heart Failure: Evidence for a Role of Driver Regions
  Journal of Cardiovascular Electrophysiology, 2005
• Mice with Cardiac-Restricted Angiotensin-Converting Enzyme (ACE) Have Atrial Enlargement, Cardiac Arrhythmia, and Sudden Death
  The American Journal of Pathology, 2004
• Angiotensin-converting enzyme inhibitors as adjunctive therapy in patients with persistent atrial fibrillation
  American Heart Journal, 2004
• Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease
  Heart, 2004
• Dissociation Between Ionic Remodeling and Ability to Sustain Atrial Fibrillation During Recovery From Experimental Congestive Heart Failure
  Circulation, 2004
• Pirfenidone effectively reverses experimental liver fibrosis
  Journal of Hepatology, 2002
• Inhibition by angiotensin II type 1 receptor antagonist of cardiac phenotypic modulation after myocardial infarction
  Journal of Molecular and Cellular Cardiology, 1995
• A computer model of atrial fibrillation
  Published by Elsevier ,1964